e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Diffuse parenchymal lung disease III
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical features and CT findings of anti-Jo-1 antibody positive interstitial lung disease with or without polymyositis and dermatomyositis
M. Tanaka, M. Arita, H. Tachibana, T. Ishida, T. Nakazawa (Kurashiki, Japan)
Source:
Annual Congress 2013 –Diffuse parenchymal lung disease III
Session:
Diffuse parenchymal lung disease III
Session type:
Thematic Poster Session
Number:
3810
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Tanaka, M. Arita, H. Tachibana, T. Ishida, T. Nakazawa (Kurashiki, Japan). Clinical features and CT findings of anti-Jo-1 antibody positive interstitial lung disease with or without polymyositis and dermatomyositis. Eur Respir J 2013; 42: Suppl. 57, 3810
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Characterization of interstitial pneumonia associated with clinical amyopathic dermatomyositis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Clinical features of interstitial lung disease in polymyositis and dermatomyositis
Source: Eur Respir J 2006; 28: Suppl. 50, 828s
Year: 2006
Are there any clinical differences between SSc-ILD and UCTD suspected of SSc -ILD?
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Nine cases of interstitial lung disease associated with anti-CADM140 antibody positive dermatomyositis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012
Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Clinical manifestations of systemic sclerosis (SS) accompanied with pulmonary involvement
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Usefulness of a myositis antibody immunoblot in diagnosis of connective tissue disease (CTD) related interstitial lung disease (ILD)
Source: International Congress 2014 – ILDs 4
Year: 2014
Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Interstitial lung diseases associated with amyopathic dermatomyositis
Source: Eur Respir J 2006; 28: 1005-1012
Year: 2006
Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Prognostic relevance of histologic features in nonspecific interstitial pneumonia (NSIP)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005
Interstitial lung disease with autoimmune features
Source: Eur Respir Mon 2011; 54: 104-117
Year: 2011
Usefulness of skeletal muscle MRI in the diagnosis of polymyositis initially presenting with interstitial lung disease (ILD)
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020
Utility of myositis related antibodies in interstitial lung disease and suspected autoimmunity.
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019
Interstitial lung disease
Source: Eur Respir Rev 2013; 22: 26-32
Year: 2013
Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis
Source: Eur Respir J 2003; 22: 245-250
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept